Milestone Scientific Inc. (MLSS)

Market Cap	28.43M -61.7%
Revenue (ttm)	8.97M +4.0%
Net Income	-5.72M
EPS	-0.07
Shares Out	88.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	207,866
Open	0.3224
Previous Close	0.3240
Day's Range	0.3103 - 0.3290
52-Week Range	0.2181 - 1.1100
Beta	0.85
Analysts	Buy
Price Target	1.00 (+211.04%)
Earnings Date	May 14, 2026

About MLSS

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery sys...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 3, 1995
• Employees: 15
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: MLSS
• Website: https://www.milestonescientific.com

Financial Performance

In 2025, Milestone Scientific's revenue was $8.97 million, an increase of 3.99% compared to the previous year's $8.63 million. Losses were -$5.72 million, 21.4% more than in 2024.

Analyst Summary

According to one analyst, the rating for MLSS stock is "Buy" and the 12-month stock price target is $1.0.

Price Target

$1.0

(211.04% upside)

Analyst Consensus: Buy